# US 6,730,704 B2 · 1-(aryloxy)propionoyl-2-arylsulfonyl hydrazines, process for preparation thereof and use thereof as hypoglycemic agents

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,730,704 B2
- Document ID: US6730704B2
- Status: Granted
- Kind: B2
- Application number: 10/108,925
- Filed: 2002-03-29
- Published: 2003-10-02
- Granted: 2004-05-04
- Earliest claimed: 2002-03-29
- Assignees: Council of Scientific and Industrial Research
- Inventors: Ramalingam Thallapalli; Venkata Durga Nageswar Yadavalli; Ramakrishna Sistla; Adari Bhaskar Rao; Prakash Vamanrao Diwan; Jhillu Singh Yadav; Kondapuram Vijaya Raghavan
- Web page: https://patentgrep.com/patent/US6730704B2

## CPC

- C07C 311/49: to nitrogen atoms
- A61K 31/325: Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof (thiurams A61K31/145)
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention relates to 1-(aryloxy)propionoyl-2-arylsulfonyl hydrazines useful as hypoglycemic agents, and to a process for synthesis thereof. The present invention also relates to the synthesis of 1-(aryloxy)propionoyl-2-arylsulfonyl hydrazines as new hypoglycemic agents which may be useful in the treatment of diabetes.

## Claims

### Claim 1

1-(aryloxy)propionoyl-2-arylsulfonyl hydrazine of the formula
wherein R is selected from 4-Cl, 3-CH3-4-Cl and 2,4-Cl2, R1 is selected from H, Cl, and CH3.

### Claim 2 (depends on 1)

1-(aryloxy)propionoyl-2-arylsulfonyl hydrazine as claimed in claim 1 of the formula

### Claim 3 (depends on 1)

1-(aryloxy)propionoyl-2-arylsulfonyl hydrazine as claimed in claim 1 of the formula

### Claim 4 (depends on 1)

1-(aryloxy)propionoyl-2-arylsulfonyl hydrazine as claimed in claim 1 of the formula

### Claim 5 (depends on 1)

1-(aryloxy)propionoyl-2-arylsulfonyl hydrazine as claimed in claim 1 of the formula

### Claim 6 (depends on 1)

1-(aryloxy)propionoyl-2-arylsulfonyl hydrazine as claimed in claim 1 of the formula

### Claim 7 (depends on 1)

1-(aryloxy)propionoyl-2-arylsulfonyl hydrazine as claimed in claim 1 of the formula

### Claim 8 (depends on 1)

1-(aryloxy)propionoyl-2-arylsulfonyl hydrazine as claimed in claim 1 of the formula

### Claim 9 (depends on 1)

1-(aryloxy)propionoyl-2-arylsulfonyl hydrazine as claimed in claim 1 of the formula

### Claim 10 (depends on 1)

1-(aryloxy)propionoyl-2-arylsulfonyl hydrazine as claimed in claim 1 of the formula

### Claim 11

A process for the synthesis of 1-(aryloxy)propionoyl-2-arylsulfonyl hydrazines of the formula
wherein R is selected from 4-Cl, 3-CH3-4-Cl and 2,4-Cl2, and R1 is selected from H, Cl, and CH3, which comprises reacting an aryloxypropionic acid hydrazide with an arylsulfonyl chloride.

### Claim 12 (depends on 11)

A process as claimed in claim 11 wherein aryloxy is selected from the group consisting of 4-chlorophenoxy, 3-methyl-4-chlorophenoxy and 2,4-dichlorophenoxy groups.

### Claim 13 (depends on 11)

A process as claimed in claim 11 wherein aryl is selected from the group consisting of phenyl, 4-chlorophenyl and 4-tolyl.

### Claim 14

A method of treating hypoglycemia, which comprises administering, to a patient in need of such treatment, a dose effective amount of a 1-(aryloxy)propionoyl-2-arylsulfonyl hydrazine of the formula
wherein R is selected from 4Cl, 3-CH3-4Cl and 2,4-Cl2, and R1 is selected from H, Cl, and CH3.

### Claim 15 (depends on 14)

A method of treating hypoglycemia as claimed in claim 14, which comprises administering said 1-(aryloxy)propionoyl-2-arylsulfonyl hydrazine in a dose of from 50 to 200 mg per kilogram of body weight.

### Claim 16 (depends on 11)

A process as claimed in claim 11, which comprises preparing a solution of aryloxypropionic acid hydrazine in dry pyridine and adding an arylsulfonyl chloride to said solution to form a reaction mixture.

### Claim 17 (depends on 16)

A process as claimed in claim 16, which further comprises refluxing said reaction mixture for a time period of from 5 to 8 hours.
